Eiger BioPharmaceuticals | 8-K: Current report
Eiger BioPharmaceuticals | 8-K: Current report
Eiger BioPharmaceuticals | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Moshe Arkin(3.58%)
Eiger BioPharmaceuticals | 8-K: Current report
Eiger BioPharmaceuticals | 8-K: Current report
Eiger BioPharmaceuticals | 8-K: Current report
Eiger BioPharmaceuticals | 8-K: Current report
Eiger BioPharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Ameriprise Financial, Inc.(0.00%),Columbia Management Investment Advisers, LLC(0.00%), etc.
Eiger BioPharmaceuticals | 8-K: Current report
Eiger BioPharmaceuticals | 8-K: Current report
Eiger BioPharmaceuticals | 10-K/A: Annual report (Amendment)
25-NSE: Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities (and amendment thereto)
Eiger BioPharmaceuticals | 10-K: Annual report
Eiger BioPharmaceuticals | 8-K: Current report
Eiger BioPharmaceuticals | S-8 POS: S-8 POS
Eiger BioPharmaceuticals | S-8 POS: S-8 POS
Eiger BioPharmaceuticals | S-8 POS: S-8 POS
Eiger BioPharmaceuticals | S-8 POS: S-8 POS
Eiger BioPharmaceuticals | S-8 POS: S-8 POS
Eiger BioPharmaceuticals | NT 10-K: Others
No Data